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Abstract
Background:  Sperm adhesion molecule 1 (SPAM1) is the major mammalian testicular
hyaluronidase and is expressed at high levels in sperm cells. SPAM1 protein is important for
penetration of the cumulus cell layer surrounding the ovum, and is also involved in zona pellucida
binding and sperm intracellular signalling. A previous study had identified SPAM1 as one of the many
human genes that initiate within a transposable element.
Results: Examination of the human, mouse and rat SPAM1 loci revealed that transcripts initiate
within the pol gene of an endogenous retrovirus (ERV) element. This is highly unusual, as all
previously identified ERV-initiated cellular gene transcripts initiate within the viral long terminal
repeat promoter. The SPAM1  locus therefore represents an example of the evolution of a
promoter from protein-coding sequence. We have identified novel alternative promoter and
splicing variants of human and murine SPAM1. We show that all transcript variants are expressed
primarily in the testis and are predicted to encode identical proteins.
Conclusion: The testis-specific promoters of the human and mouse SPAM1 genes are derived
from sequence that was originally part of an ERV pol gene. This represents the first known example
of an ERV-derived promoter acting in a gender-specific manner.
Background
Sperm adhesion molecule 1 (SPAM1, also known as PH-
20) is a member of a family of at least six mammalian
hyaluronidases. The genes encoding these enzymes cluster
in two groups of three – SPAM1, HYAL4 and HYALP1 (a
pseudogene) on human chromosome 7q31, and HYAL1,
HYAL2 and HYAL3 on human chromosome 3p21 [1,2].
The orthologous mouse genes form similar clusters at syn-
tenic chromosomal locations [1]. This suggests that two
single-gene duplications, followed by a small segmental
duplication, occurred before the divergence of human and
mouse approximately 80 million years ago.
HYAL4 exclusively degrades chondroitin. In contrast,
HYAL1, HYAL2, HYAL3 and SPAM1 hydrolyze hyaluronic
acid, with different substrate size preferences and tissue
specificities [1-3]. Expression of SPAM1 has been unani-
mously reported in the testis in various species (reviewed
in [1,4]). Expression has also been detected in the human
epididymis, vas deferens, prostate and placenta [2,5] and
the murine epididymis, kidney, uterus, vagina and ovi-
duct [6-8]. Expression of SPAM1 has not been detected in
the human female reproductive tract [2,9].
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SPAM1 has various functions in fertilization. A catalytic
domain has been shown to degrade hyaluronic acid
[10,11]. This molecule is a major extracellular matrix
component of the cumulus cell layer that surrounds the
ovum, and SPAM1 has been shown to remove this cumu-
lus layer in vitro [12]. SPAM1 has hyaluronic acid and
zona pellucida binding regions that are distinct from its
catalytic domain [13,14] and is also involved in an intra-
cellular signalling pathway in sperm cells upon binding to
the zona pellucida [4,15,16].
The role of murine SPAM1 in fertilization has been inves-
tigated using a knockout mouse line. Sperm from Spam1 -
/- mice showed a delay in the removal of the cumulus cell
layer and fertilization in vitro. Surprisingly, however,
Spam1 -/- males showed normal in vivo fertility rates and
sired normal-sized litters [17]. Sperm from Spam1 -/- mice
maintained 40% of the wild-type level of hyaluronidase
activity, while protein expression assays indicated the
presence of a second hyaluronidase in these cells [17].
This was unexpected, as SPAM1 was thought to be the
only testicular hyaluronidase. These results may be
explained by recent evidence that the murine orthologue
of the human HYALP1 pseudogene has an intact ORF and
is expressed in mouse testis [1,3,18], and that a seventh
hyaluronidase,  Hyal5, may exist in mouse, but not in
human [3,18]. There may therefore be some redundancy
among murine testicular hyaluronidases that explains the
fertility of Spam1 -/- mice. In this case, it remains likely that
SPAM1 is an essential protein in human fertilization.
Little is known about the transcriptional regulation of
SPAM1. A non-consensus cAMP response element (CRE)
in the murine Spam1 promoter bound the testis-specific
CRE modulator (CREM) protein and was involved in acti-
vation of Spam1 transcription in vitro [19]. In addition,
Spam1 expression was abolished in CREM-deficient mice
[19]. Various other putative transcription factor binding
sites have been identified in the human, mouse and rat
SPAM1 promoters [5-7,19,20]; however, the sites are gen-
erally non-consensus and have not yet been shown to be
functional. The restricted developmental and spatial
expression of SPAM1 [5,7,21], as well as the unique tran-
scriptional mechanisms employed during spermatogene-
sis (reviewed in [22]), may render SPAM1 unamenable to
traditional methods of transcription and promoter
analysis.
In a previous study by our group, SPAM1 was identified as
one of the many human transcripts that contain transpos-
able element (TE) sequence [23]. TEs include long and
short interspersed nuclear elements (LINEs and SINEs),
DNA transposons, and endogenous retroviruses (ERVs).
TEs are extremely common in the human and mouse
genomes, and together contribute 45% and 40% of the
total sequence, respectively [24,25]. Many human and
mouse gene transcripts contain TE sequences in their
untranslated regions (UTRs) [23,26,27]. TEs also contrib-
ute to the transcriptional regulation of many genes. The
antisense LINE1 promoter and the long terminal repeat
(LTR) promoters of ERVs are known to participate in the
tissue-specific expression of various host genes [28-30].
Through bioinformatic analysis, human and mouse
SPAM1  transcripts were predicted to initiate within an
antisense ERV [23], indicating that this gene may repre-
sent another example of transcriptional regulation by a
TE.
In this study, we show that the first exons and proximal
promoter regions of the human and rodent SPAM1 genes
are derived from an ERV1 pol coding region, and identify
novel alternative promoters and splicing variants of the
gene. We show that the human and mouse ERV-derived
promoters are largely testis-specific, and discuss the impli-
cations of ERV insertion on the evolution of transcrip-
tional regulation at this locus.
Results
The human SPAM1 gene initiates within an ERV1 pol 
region
A recent study by our group used bioinformatic methods
to investigate the contribution of TEs to human and
mouse gene transcripts [23]. That study determined that
3.1% of human RefSeq genes initiate within a TE
sequence, indicating that these genes are candidates for
transcriptional regulation by TEs. One example identified
in this way was the SPAM1 gene, where the 5'-terminus
was found to map within an antisense ERV element. We
have now investigated this locus in more detail.
We used the University of California at Santa Cruz
(UCSC) genome browser at http://www.genome.ucsc.edu
to more closely examine the genomic region surrounding
the first exon of SPAM1. The region bears the hallmarks of
multiple TE insertions into older, pre-existing repetitive
elements, resulting in a "patchwork" effect of fragmented
TEs from different families (Figure 1B, 2). The previously
described SPAM1 transcriptional start site (nucleotide +40
in exon 1A) mapped within an antisense ERV1 element of
the MER34 family (Figure 1B, 2). Surprisingly, the ERV
sequence was derived not from an LTR, but rather from an
internal retroviral region. This is counter to all previously
described examples of transcription initiation within an
ERV. To confirm this RepeatMasker annotation, we per-
formed a BLAST homology search of the translated retro-
viral sequence against a protein database. This analysis
confirmed that SPAM1 transcripts initiate within a frag-
ment of the ERV1 pol gene.BMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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Genomic structure of human SPAM1 Figure 1
Genomic structure of human SPAM1. (A) Overview of the SPAM1 locus. Exons are boxed and numbered, with the size in 
bp shown above. Intron sizes in kb are shown below. The approximate positions of the SPAM1 ORF start and stop codons are 
indicated. The four SPAM1 splicing variants are shown schematically below. ERV-derived sequences are shown in green, with 
other sequences in blue. The diagram is not to scale. A black bar indicates the region shown in more detail in Figure 1B and 2. 
(B) The positions of SPAM1 alternative first exons 1A and 1B with respect to TE sequences. Exons are represented by solid 
black boxes. Bent arrows indicate the position and relative usage of the 5'-most transcription start site for each exon. TEs are 
represented by the colored boxes below; arrows indicate the orientation of each TE.
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The sequence and position of SPAM1 exons 1A and 1B with respect to TEs Figure 2
The sequence and position of SPAM1 exons 1A and 1B with respect to TEs. The sequence shown corresponds to 
human chromosome 7 co-ordinates 123158485 to 123160464 in the UCSC genome browser (May 2004 release). Solid lines 
define the boundaries between different TE sequences. The class and orientation (F, forward; R, reverse) of each TE are given 
on the right hand side. Exon sequences are shown in upper case reverse type. The dotted white line frames the portion of 
exon 1A included in splicing variant 1A1, but not variant 1A2. The transcription start sites identified by 5'-RACE are under-
lined, and splice donor sites are shown in bold italic type. A non-consensus CRE is shown in bold underlined type.
ttatgacctccatgatgggtttgaggatgtggtgtatggagtcaaactacagggtttgat
tgcaatattgtcttggattgttacttgggaagagatcagtaccatatttgtttttaattg
gaaaagtctttttcttccaatgtctttatttgagcaagggacaattcttgagcttacata
gaggtttttccttgcccagtgaactcaccagaaggaaaagtagagtgacattgtttttct
gaccatggataccatactctttcattcatttatcttccatagttggtccacctggtaccc
catggacaggaataaaaactaattcaggtttgttcatgctatcagatgttgacataagca
ataattatattgtttagctgacatgaccaaggtttgggaaactggtgcaagggtggtgtc
aggtttgtgtttaacctatgaagaaaagagtgaggttaatatgaaagaggcagcatttga
aagaaagcccacagtggaggatcagagagagaataggatagattgagacaagtaatctcc
agtcagcttctcaataaatgggaggttttgttgaaaaagatcccccctctactcccctcc
ccacaccagggaggaaagaaacttaaagggggaaaatagatgaaagcaaagttttttatc
tgtgatcttgaggaaagctgtttgctttgtggtgtcatcttgcttctagagccttggctc
1A +1
tgaaatccttactatgaggtcacctgtagggatggtCTTCCAGTTGTCCTGAGAGTGATG
ACTGGCTCCACCTTGATGTGGCTCACATAAATTCAGAAAGTATGATAGCAGTGTAGGTGG
TTAGCAGCACCTCATAAGGTCCTTCCTAGCAAGGTAACAGTACAAGCTTTTTCTAAAAAT
CTTGATGTATACCTGATCTCCTGGTTGAAAGAGTTGGCTTGATGGATTTTTTCCTATAAG
TTCTTTTTATGTCTAGATTTTTATGTTCCACTTGACCTGATGATTGAGGATGGTATGAAG
TAAGAAGTTTTAATGAGTAATCCAGAGATTTTgtgagtgagtggtttatttctactaaaa
aatgagttccttggtctgattcaatctataaagaaatgccaaaatgaggaataacctcag
tcgttaatttctttaccactatcatggtgttgcatgaacctggcagatggcggttttagt
gagccgagatcatgccactacactccatcctgggtgacagagtgagactctgtcacaaaa
aaaaaaaaaaaggcattacaatggagggattggttaataagacctgtgtataggtggtct
gctactgtgttgcgaggtgctgtgtcttattaagtcataagagaatggacacagaatggg
1B +1
agaatggggaacgtggaggtAAAGGAGGGAACCTAATGTAAGAATACTGAATTTGCCAAT
TAAGGCACCAGCTGTGACTACTTCATACAGGAATGGGGACATGCCTGATGCCATAGGGTC
TAATTGACTTGAGAATGTGAAAGGAAAATAAAAACTCAGAACCCCAATTCATCATGCCAA
AAGGAAAAAAAAATTAAGCTGAAATgtgagttgtgcaagaaactgccttttctcttgttc
ctaagcagatagctagagataaaatgttaactccacaggtagttactctgtgttcacctt
atcttatgtaaagtgcagatttactgagcactggatgaatacataattgactattcccct
acctacttcttttcccttgcaacatgtggattatcataccctccttctttccccgccggc
ctgcttttcccctttaaataccgaggccctcaaattcatttttagaaaaaggcacggacc
acagactgtttctgtgactccatgtttatttgttctgggcttatccttaactttggcaaa
ataaacttctaaattgattgagacctgtctctgatactttttggtttaccagaaatatag
ERV1 MER4C LTR (F)
ERV1 MER34D pol (R)
ERV1 MER34D pol (R)
Alu Sg/x (F)
Exon 1A
Exon 1BBMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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The alternative promoters and splicing variants of SPAM1
We performed 5'-rapid amplification of cDNA ends
(RACE) to confirm the position of the SPAM1 transcrip-
tional start site. Since expression of SPAM1 is confined
largely to the testis, we used human testis RNA for this
analysis. Sequencing of 5'-RACE clones identified two
alternative first exons of SPAM1 (Figure 1, 2). We have
designated the upstream, previously-identified first exon
as exon 1A, and the novel downstream first exon as exon
1B. Exon 1A is wholly derived from the antisense ERV1 pol
region. Exon 1B initiates within a different fragment of the
same pol gene, but terminates within a sense orientation
LTR of the ERV1 MER4C family (Figure 1B, 2). Transcripts
containing both alternative first exons spliced into the
same downstream exons; the SPAM1 ORF begins in exon
4, and is therefore not affected by alternative promoter
usage (Figure 1A).
Multiple transcription start sites were identified within
exon 1A, at position +1, +6, +20 and +51 (Figure 2). We
also identified a splicing variant of exon 1A, with variant
1A2 using a splice donor site at position +118. Use of this
alternative splice site resulted in a truncated 117 bp first
exon, as opposed to a full-length size of 296 bp for variant
1A1 (Figure 1A, 2). In contrast, a single transcription start
site and no splicing variants were observed for exon 1B.
However, some transcripts initiating within exon 1B con-
tained a novel alternatively-spliced 85 bp exon (Figure
1A). The sequences of all human and murine SPAM1
splicing variants have been deposited in GenBank with
accession numbers AY920278 – AY920283.
Both ERV-derived promoters are male-specific
To verify the expression patterns of the SPAM1 alternative
promoter and splicing variants, we performed non-quan-
titative RT-PCR on a panel of RNAs derived from normal
human tissues. As shown in Figure 3, expression of tran-
scripts containing SPAM1 ORF sequence was detected in
the testis, as well as the heart, small intestine, prostate,
muscle and placenta. Primers designed to amplify both
exon 1A splicing variants detected transcripts only in the
testis and prostate, while exon 1B-specific transcripts were
detected in the testis, prostate, and to a lesser degree in the
placenta. The smaller of the two splicing variants was pre-
dominant for both promoters; this may be due to an
amplification bias introduced by the PCR.
We next used real-time RT-PCR to quantify the level of
SPAM1 transcripts and the contribution of each alterna-
tive promoter to total gene expression. Primers annealing
to exon 4 and exon 5, common to all SPAM1 transcripts
(Figure 1A), were used to determine the level of total gene
expression. This value was normalized to the level of
GAPDH transcripts and expressed relative to that obtained
Detection of SPAM1 transcripts by RT-PCR Figure 3
Detection of SPAM1 transcripts by RT-PCR. Primer pairs specific for GAPDH, the SPAM1 ORF, and SPAM1 transcripts ini-
tiating within exon 1A or 1B were used in RT-PCR assays. Assays were carried out on cDNAs derived from a range of normal 
human tissues: 1, brain; 2, heart; 3, kidney; 4, liver; 5, lung; 6, bone marrow; 7, colon; 8, small intestine; 9, spleen; 10, stomach; 
11, thymus; 12, mammary gland; 13, prostate; 14, muscle; 15, testis; 16, uterus; 17, spinal cord; 18, placenta. Approximate 
molecular weights are indicated on the left.
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for the heart, which showed a low level of SPAM1 expres-
sion (Figure 4). As expected, SPAM1 was highly expressed
in the testis, although low levels of expression were also
detected in the prostate and some other tissues.
On the basis of the results obtained with the ORF-specific
primers, we decided to quantify the expression of exon 1A
and 1B transcripts only in the testis. To avoid amplifica-
tion of different-sized products from alternatively-spliced
SPAM1  transcripts, we designed forward primers that
spanned two exons. The forward primer for exon 1A tran-
scripts contained 14 bases that anneal to the 3'-end of
truncated exon 1A2, and 5 bases that anneal to the 5'-end
of exon 3. Similarly, the forward primer for exon 1B tran-
scripts contained 18 bases that anneal to the 3'-end of
exon 1B, and 5 bases that anneal to the 5'-end of exon 3.
Each forward primer was used with a reverse primer spe-
cific to the 3'-end of exon 3. In this way, only the smaller
of the two splicing variants originating in each first exon
was amplified (see Figure 1A and Table 1). The levels of
transcripts detected with these primer pairs were used to
calculate the contribution of each ERV-derived promoter
to total gene expression. As shown in Figure 4, exon 1A
transcripts were approximately 10-fold more abundant
than those initiating in exon 1B, accounting for 78% of
total SPAM1 expression in the testis compared to 7.6% for
exon 1B transcripts. The 14% of SPAM1 ORF transcripts
not accounted for by these primer pairs most likely corre-
spond to splicing variants 1A1 and 1B1, which were
excluded from this analysis.
The results obtained by non-quantitative RT-PCR (Figure
3) and quantitative, real-time RT-PCR (Figure 4) were gen-
erally similar. However, transcripts containing SPAM1
ORF sequence were detected in the small intestine and
muscle by the former method, but not the latter. The
bands amplified from these tissues by non-quantitative
RT-PCR were sequenced and were confirmed to
correspond to the predicted SPAM1 ORF transcript. 5'-
RACE analysis performed on human muscle total RNA
Quantitative analysis of SPAM1 expression in normal human tissues Figure 4
Quantitative analysis of SPAM1 expression in normal human tissues. Primers were used in real-time RT-PCR assays 
to amplify transcripts specific for GAPDH and total SPAM1 transcripts, and, in testis only, for SPAM1 transcripts initiating in 
exon 1A and 1B. Green bars represent the relative abundance of total SPAM1 transcripts normalized to GAPDH. Solid and 
hatched blue bars represent the contribution of exon 1A and 1B transcripts, respectively, to total SPAM1 expression. All bars 
represent the mean of four independent assays ± standard deviation.
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identified a low level of transcripts initiating within pro-
moter 1B, but no other SPAM1-specific transcripts (data
not shown). These results suggest that the 35 cycles used
for non-quantitative RT-PCR analysis amplified tran-
scripts present at levels too low to be detected by real-time
RT-PCR.
ERV1-derived promoter 1A is conserved in the mouse 
genome
Initial analysis of SPAM1 revealed that transcripts of the
mouse orthologue, Spam1, also initiate within an ERV
[23]. Examination of the mouse genomic sequence
revealed that, as in human, the published 5'-ends of the
Spam1 first exon (nucleotides +12, +21, +48 and +68 in
Figure 5B[6,19]) map within an antisense ERV1 MER34
pol region (Figure 5B). A similar overlap between Spam1
transcripts and an antisense ERV1 pol region was observed
in the rat genome (data not shown). This ERV1 element
therefore inserted into the ancestral genome before the
divergence of humans and rodents, approximately 80 mil-
lion years ago.
The RepeatMasker track of the UCSC genome browser
annotated only a 342 bp region of the murine Spam1
locus as ERV1 pol sequence; the analogous pol fragment
containing human SPAM1 exon 1A is considerably larger
(compare Figure 2 and 5B). Due to the higher neutral
mutation rate in mouse [24], murine TEs that inserted
prior to the primate-rodent split are roughly twice as
diverged as the orthologous human element, making
detection by repeat-finding programs difficult. Older ele-
ments in rodents are therefore often excluded from
annotation as TEs in the RepeatMasker database [24,31].
We used the DOTTER sequence comparison program to
determine whether this was the case for the ERV1
sequence associated with Spam1. We extracted the human
genomic DNA sequence containing the full-length exon
1A1 and 1000 bp of upstream sequence (1296 bp in total)
from the UCSC genome browser. We also extracted the
mouse genomic sequence containing exon 1 and 734 bp
of upstream sequence (a total of 858 bp). A Dot Plot
showing a comparison of these two sequences is shown in
Figure 6A.
The sequence annotated as the ERV1 pol  region in the
human genome corresponds to nucleotides 246 – 1296 in
Figure 6A (nucleotides -754 to +296 in Figure 2). The
positions of the ERV1 pol region and the exon 1A tran-
scriptional start site are shown below the lower horizontal
axis. The mouse genomic sequence from approximately
nucleotide 100 – 800 in Figure 6A shows some sequence
similarity to nucleotides 300 -1050 of the human
sequence. Therefore the region of the mouse Spam1 locus
derived from the ERV1 pol region is considerably larger
than that annotated by RepeatMasker, extending approxi-
mately 700 bp upstream of the transcriptional start site.
The positions of the annotated and extended ERV1 pol
regions are represented by solid and dashed boxes, respec-
tively, on the right hand side of Figure 6A. A similar DOT-
TER result was observed upon comparison of the
corresponding rat and human genomic sequences (data
not shown).
The level of sequence similarity between the human and
mouse SPAM1 promoter regions is highest at position 900
– 950 in the human sequence and 650 – 700 in the mouse
(Figure 6A, region marked with asterisk). A sequence com-
parison revealed that this conserved region contains the
functional CRE identified in the murine Spam1 promoter
(Figure 6B, reference [19]). The relatively high level of pri-
mate – rodent conservation of this element and the sur-
rounding sequence indicates that this region may be
functionally important.
We performed 5'-RACE on mouse testis RNA to identify
the transcriptional start site(s) and to search for alterna-
tive promoters of Spam1. As shown in Figure 5, a single
first exon with multiple transcriptional start sites was
identified for Spam1. This exon is orthologous to exon 1A
of the human gene (Figure 6A). No sequence equivalent
to human exon 1B was detected in mouse Spam1 tran-
scripts. Two splicing variants were identified for the
Table 1: Primer positions and sequences
Primer 
namea
Exon Sequence (5'-3')
HGF1 6 CATGAGAAGTATGACAACAGCCTC
HGF2 8 TGGTCTCCTCTGACTTCAAC
HGR1 9 GTTGCTGTAGCCAAATTCGTTGTC
HGR2 9 CTGTAGCCAAATTCGTTGTC
HSF1 4 CTACACTCTATGTGCGCAATCG
HSF2 1A TAGCAGTGTAGGTGGTTAGCAG
HSF3 1B GGGTCTAATTGACTTGAGAATGTG
HSF4 4 TTTTTGCATATACCCGCATAG
HSF5 1A-3 TCCTTCCTAGCAAGGGATG
HSF6 1B-3 AAAAAATTAAGCTGAAATGGATG
HSR1 6 TTTGGCTGCTAGTGTGACGTTG
HSR2 4 CTGATGCAAAGTATGAGCACAG
HSR3 4 CATTCCAGGCCCAGAGGAAAG
HSR4 5 CCCATATTACAATTCCAGAAG
HSR5 3 AAGTCTGCTTTCAAAATCCAG
MGF 3 GTGGAGTCTACTGGTGTCTTC
MGR 5 GTGGCAGTGATGGCATGGAC
MSF1 4 GATGCTATGAGTTTAGCACAACG
MSF2 1 ATGATGGAGATGCGAGTGGTAG
MSR1 5 CATCAGATGTCTCCTTACATGTC
MSR2 3 TGTGGTCTGTTTAGTATTAGATGC
MSR3 3 TTCCTTCTTACACACTGTGGTC
a) H, human; M, mouse; G, GAPDH; S, SPAM1; F, forward; R, reverse.BMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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Genomic structure of murine Spam1 Figure 5
Genomic structure of murine Spam1. (A) Overview of the Spam1 locus. Exons are boxed and numbered, with the size in 
bp shown above. Intron sizes in kb are given below. The approximate positions of the Spam1 ORF start and stop codons are 
indicated. The two Spam1 splicing variants are shown schematically below. ERV-derived sequences are shown in green, with 
other sequences in blue. The diagram is not to scale. A black bar indicates the region shown in more detail in Figure 5B. (B) 
Sequence and position of Spam1 exons 1 and 2 with respect to TE sequence. The sequence shown corresponds to mouse 
chromosome 6 co-ordinates 24623802 to 24624821 in the UCSC genome browser (May 2004 release). The solid line frames 
the sequence annotated as ERV1 MER34 pol sequence in the RepeatMasker database. Spam1 exon sequences are shown in 
upper case reverse type. Splicing variant 2 sequences are shown in bold type. The transcription start sites identified by 5'-
RACE are underlined; splice donor and acceptor sites are italicized. A non-consensus CRE is shown in bold underlined type.
B)
ctgcataatgaaaatagaaaagccaagtctattttccataaaagcaaataaaaatctttc
actgtcatcttctgaacaggaaacagacttgtgtttcactggagattttcctaggcatga
agtttcaacaggaggaaaggtagcaggatgctactctctggtcacaaatgctatccagtt
ttaatcaaaccatcttaacagtagttctactagatgctcactgtgagtatctagtagaat
tgcagggatgaaagctaatgacataatgtttcatgctacctacatgctgcaattactgca
aggatttgttaatatggcaaggttttgggttgtatgatttttgtgattaattcagaaaac
aatacagttaaaaggagagtcacatgtctgaaagctgaatagattgagaaaagtatatca
gccagacttcataggaaagaagtgaatcaggaaatttttgtttcccctgaaaggatggga
gagttgaaggaagagggaaaggggtggtctgtgagcttgggagaatcagttcactttgtg
+1
atgtcatctgttcctagaatcttggaatttgctctggctttcccCTTGGCTTATTCTAAG
AGTGCTGAAGTAGATTTAGATTGACCATGGCTCACATGAATTAAGAAGTGTTTCTTTTGT
TATGATGGAGATGCAGATGGTAGGCAGGTATTTTAAGTTTCCAGCAAGgtaacagtatac
atgctttttataaacttcttgattttctctctcttctttttttctttagGTGAAAGTGAT
GAAAGAATTGTCACTCAGTGGAAGgtatattttctcactgatgcccctactgtgttacag
ttgtcataattttcaagtggtagtgtcaaagtatccatttaagcccctttaaaatccatt
taactcaggaactcaagattcaaagatgctaggatagaaccaattgactttcatgcctta
gcctaccatggtttgaaacatcgtaacaattttatgtccatgtatgattggaatatcaga
Exon 1
Exon 2
124 35 1152 90 741
3 4 5
ORF
A)
Variant 1
Variant 2
0.09 4.4 0.79 2.4
2 1BMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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Comparison of the genomic sequence upstream of the human and mouse SPAM1 genes Figure 6
Comparison of the genomic sequence upstream of the human and mouse SPAM1 genes. (A) DOTTER compari-
son of the human (horizontal axis) and mouse (vertical axis) genomic DNA sequences upstream of the SPAM1 / Spam1 locus. 
Nucleotide positions in bp are given on the upper horizontal and left vertical axes. The approximate position of the human 
ERV1 MER34 pol region is shown below the lower horizontal axis. The approximate positions of the annotated mouse ERV1 
MER34 pol region (solid box) and of the extended pol sequence (dashed box) are shown on the right hand side. The 5'-most 
transcriptional start site of each gene is represented by a bent arrow. An asterisk marks the approximate position of a con-
served CRE in the proximal human and mouse promoters. (B) Multi-species alignment of the well-conserved sequence marked 
with an asterisk in Figure 6A. Nucleotides identical between the human and mouse sequence are joined by vertical lines. Nucle-
otides identical between the mouse and rat sequence are highlighted in gray. The mouse-rat alignment is incomplete in this 
region due to a small (56 bp) insertion into the rat sequence. The MER34 ERV1 consensus sequence is shown above the human 
SPAM1 promoter sequence; nucleotides identical between the two sequences are shown in reverse type. Solid lines above and 
below the sequence indicate the position of the conserved CRE. The 5'-most human and mouse transcriptional start sites are 
marked with bent arrows.
A)
ERV1 pol
*
Human
M
o
u
s
e
B)
MER34 TGATCCGTGATCTTGGGAAAAGCTGTCTACTTCATGATGCCGTC.TGCTTCCGGGGCCTG
Human TTATCTGTGATCTTGAGGAAAGCTGTTTGCTTTGTGGTGTCATCTTGCTTCTAGAGCC..
| ||||||| |||| | || | ||| ||||||| ||||||| || | ||||| |
Mouse TGGTCTGTGAGCTTGGGAGAATCAGTTCACTTTGTGATGTCATC.TGTTCCTAGAATC..
Rat TGGTCTGTGAACTTGGGAGAATCAATTCACTTTGTGATGTCATC.TGCTTCTAGAACC..
MER34 GGGATTGG..CCCTGGAAATCCTTACTTTAAGGTCACCTGTAGGGATGGTCTTCCAATT
Human ....TTGG..CTCTG.AAATCCTTACTATGAGGTCACCTGTAGGGATGGTCTTCCAGTT
|||| | ||| | || | || | || | || |
Mouse ....TTGGAATTTGC.TCTGGCTTTCCCCTTGGCTTATTCTAAGAGTGCTGAAGTAGAT
Rat ....TTGGAATTTGCBMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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mouse Spam1 gene. Variant 2 utilized an alternative tran-
scription start site and splice donor site within exon 1 to
generate a truncated first exon, and spliced into a short
(35 bp) novel downstream exon (Figure 5). As with
human SPAM1, the murine splicing variants affect only
the 5'-UTR, leaving the downstream ORF intact (Figure
5A).
Expression of the mouse Spam1 gene is largely testis-
specific
We performed non-quantitative RT-PCR on a panel of
normal C57BL/6 mouse tissues to determine the expres-
sion pattern of Spam1. As shown in Figure 7, primers spe-
cific to the Spam1 ORF detected transcripts only in the
testis. Transcripts initiating within the ERV1 pol  region
were detected primarily in the testis, and to a lesser degree
in the kidney. As with the human gene, the ERV1 pol-
derived promoter of murine Spam1  is therefore largely
testis-specific.
Discussion
In this study we have experimentally confirmed a previous
in silico observation [23] that transcription of the human
and murine SPAM1 genes initiates within an antisense
ERV common to both species. SPAM1 is the only hyaluro-
nidase gene to initiate within an ERV (data not shown);
this TE insertion therefore took place after the small seg-
mental duplication of three ancestral hyaluronidase
genes, but before the divergence of primates and rodents.
Interestingly, human HYAL4, but not its mouse ortho-
logue, appears to initiate within an antisense LINE1 ele-
ment ([23] and our unpublished observations). This
element therefore inserted after the primate-rodent split,
indicating an ongoing contribution by TEs to human
hyaluronidase transcriptional regulation.
A previous study by our group determined that TE inser-
tions were more common in transcripts with a high Ka/Ks
value [23]. The Ka/Ks ratio for the human-Old World mon-
key SPAM1 orthologous pair is high at 0.57 [32]. This is in
line with our hypothesis that TE insertions are more likely
to be tolerated by rapidly-evolving genes [23]. High Ka/Ks
ratios are a common characteristic of primate genes that
are involved in male reproduction. This may be due to
positive selection, driven by competition between the
sperm of individual males of the more promiscuous
primate species [32]. In the case of SPAM1, the require-
ment for species-specific sperm-zona pellucida recogni-
tion may also have contributed to the high inter-species
divergence of the protein sequence.
Detection of Spam1 transcripts by RT-PCR Figure 7
Detection of Spam1 transcripts by RT-PCR. Primer pairs specific for Gapdh, the Spam1 ORF, and Spam1 transcripts initi-
ating within the ERV sequence were used in RT-PCR assays. The assays were carried out on cDNAs derived from a range of 
normal C57/BL6 mouse tissues: 1, brain; 2, heart; 3, kidney; 4, liver; 5, lung; 6, colon; 7, small intestine; 8, spleen; 9, stomach; 
10, thymus; 11, muscle; 12, testis; 13, placenta. Approximate molecular weights are indicated on the left.
Gapdh
ORF
ERV
265bp
265bp
330bp
12 345 67 89 1 0 1 1 1 2 1 3BMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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We have identified two closely-spaced ERV-derived pro-
moters for human SPAM1. Both were active primarily in
the testis, albeit with an approximately 10-fold difference
in promoter activity. This close physical proximity and
similar tissue specificity suggests that the two promoters
may be regulated by a shared testis-specific enhancer ele-
ment, rather than by individual tissue-specific proximal
promoter regions. We have also identified alternative
splicing variants for the human and mouse genes.
Alternatively-spliced transcripts of HYAL1  and  HYAL3
have been described that cause an in-frame deletion of the
putative catalytic site and abolish hyaluronidase function
[33]. Evidence from the NCBI database suggests that an
alternative splicing event in SPAM1 exon 6 generates an
extended 3'-transcript, which encodes a C-terminally trun-
cated SPAM1 isoform. However, the presence of this splic-
ing variant has yet to be confirmed. In contrast, the
alternatively-spliced transcripts of SPAM1  and  Spam1
described in this study differ only in the sequence and
length of the 5'-UTR, and are not predicted to affect
enzyme function. Changes in the 5'-UTR sequence may
however alter the stability and / or translation efficiency of
the transcripts (reviewed in [34]), and hence impact indi-
rectly on SPAM1 expression.
We have shown that all SPAM1 / Spam1 alternative pro-
moter and splicing variants are expressed primarily in the
testis. Lower levels of expression were also observed in the
human prostate and murine kidney. This contradicts
previous reports that human SPAM1 is expressed in the
placenta [2] and that murine Spam1 is expressed in tissues
of the female reproductive tract [7]. Expression of SPAM1
is confined to a subset of specialized cells in some tissues
[5,7], which may explain these contradictory results.
In contrast to all known examples of host gene transcrip-
tional regulation by ERVs, SPAM1 and Spam1 initiate not
within an LTR, but rather within a fragment of the pol cod-
ing region. While the SPAM1 / Spam1 promoters have not
yet been fully analyzed, a non-consensus CRE at position
-39 has been shown to be important for activity of the
murine Spam1 promoter in an in vitro testis system [19].
This site, and a similar sequence in the human promoter,
are clearly derived from the ERV1 pol region and are well
conserved between the two species (Figures 2, 5B, and 6).
Various lines of evidence suggest that SPAM1 expression is
regulated by sex hormones: the expression of SPAM1 in
the male and female reproductive organs; the increased
expression of Spam1 in male kidney compared to female
[8]; the seasonal variation in SPAM1 expression in red fox
testis [35]; and the variations in murine female SPAM1
expression at different stages of estrus [7]. Indeed, various
groups have identified putative androgen response ele-
ments (AREs) in the SPAM1  and  Spam1  promoters
[5,6,19], and estrogen response elements (EREs) in the
Spam1 promoter [7]. Many of these predicted sites also
map within the ERV pol region. However, none of these
sequences represents a consensus binding site, and none
has yet been shown to bind its cognate transcription factor
or to be required for SPAM1 expression.
Alternatively, hormonal regulation may be mediated
through the CRE. Androgen treatment of Sertoli cells was
recently shown to rapidly induce phosphorylation of a
CRE binding protein and activate transcription of target
genes via the MAPK pathway [36]. This mechanism was
postulated to represent a common mechanism for
activation of testis-specific promoters that do not contain
a consensus ARE. Much work remains to be done to eluci-
date the mechanisms of transcriptional regulation of
SPAM1 and Spam1. However, it is clear that at least one
functional transcription factor binding site is derived from
the ERV1 pol region.
ERV LTRs contain the regulatory signals necessary for tran-
scription of the retroviral genes. Insertion of an LTR
sequence near a host gene could therefore provide a novel,
pre-formed regulatory unit and be rapidly adopted by the
gene for use as an alternative promoter. It is less clear how
a retroviral protein coding region, which has no known
function in transcriptional regulation, could be adopted
for use as a promoter by a host gene. We suggest the fol-
lowing scenario.
Prior to the primate-rodent divergence, an ERV inserted
upstream of the ancestral SPAM1 gene, in the antisense
orientation. By chance, the antisense pol coding region
contained sequences that were similar to a CRE, and pos-
sibly to other transcription factor binding sites necessary
for testis-specific transcription. The region of the human
SPAM1 promoter that contains the CRE is quite divergent
from the MER34 consensus sequence (Figure 6B). It is
therefore unlikely that the CRE was functional, and hence
preserved by purifying selection, from the time of ERV
insertion. The CRE present in the modern SPAM1 and
Spam1 promoters is more likely to have evolved by ran-
dom nucleotide substitution from a similar sequence in
the original antisense pol gene. The ~50 bp of genomic
sequence that contains the CRE is relatively well con-
served between human and rodents (Figure 6), indicating
that purifying selection of this sequence probably
occurred at some time after the creation of the functional
CRE. The evolutionary origins of other functional tran-
scription factor binding sites in the modern SPAM1 /
Spam1 promoters remain to be determined.
The selective processes driving the evolution of a pro-
moter from a protein coding sequence, and the fate of the
original ancestral SPAM1  promoter, remain unknown.
This gene therefore represents an extremely intriguingBMC Genomics 2005, 6:47 http://www.biomedcentral.com/1471-2164/6/47
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example of how the host genome can adopt "parasitic"
ERV sequences for its own purposes.
Conclusion
We have shown that transcription of the human and
mouse SPAM1 genes initiates within an antisense ERV pol
gene. The first exons and proximal promoters of both
genes are derived from this ancient ERV pol  sequence.
Expression of the human and mouse SPAM1  genes is
largely testis-specific, and we have provided evidence that
testis-specific transcription factor binding sites are derived
from conserved ERV sequence in both species. SPAM1 can
therefore be added to the growing list of mammalian
genes that are regulated by TEs. This gene represents the
first known example of the evolution of promoter func-
tion from an ERV coding sequence, and of gender-specific
transcription from an ERV-derived promoter.
Methods
Computational methods
The human, mouse and rat SPAM1  /  Spam1  loci were
examined using the University of California, Santa Cruz
genome browser [37]. Homology searches were per-
formed using the Basic Local Alignment Search Tool
(BLAST, [38]). The SPIDEY alignment program [39] was
used to compare cDNA and genomic DNA sequences for
all splicing variants and for 5'-RACE clones. Human and
mouse genomic DNA sequences were compared using the
DOTTER program [40].
Reverse transcription and RT-PCR
C57BL/6 mouse testis total RNA and all human total
RNAs were purchased from Clontech. All other mouse
RNAs were extracted from C57BL/6 mouse tissues using
TRIzol (Invitrogen) according to the manufacturer's
instructions. 5 µg of each RNA was treated with DNase I
and reverse transcribed as described [41]. 35 cycles of RT-
PCR were performed using Taq DNA polymerase with 2
ng/µl of each primer in 4 mM MgCl2. Primer pairs were as
follows. GAPDH, HGF1 & HGR1; SPAM1 ORF, HSF1 &
HSR1; SPAM1 Exon 1A, HSF2 & HSR2; SPAM1 Exon 1B,
HSF3 & HSR2; Gapdh, MGF & MGR; Spam1 ORF, MSF1 &
MSR1; Spam1 ERV, MSF2 & MSR2. All primer positions
and sequences are given in Table 1.
5'-RACE
5'-RACE analysis of human or mouse testis total RNA was
carried out using the FirstChoice RLM-RACE kit (Ambion)
as described [42]. HSR3 and HSR2 were used as the outer
and inner primers, respectively, for nested RT-PCR ampli-
fication of SPAM1 5'-RACE products. MSR3 and MSR2
were used as the equivalent mouse primers.
Real-time RT-PCR
Real-time quantification of transcript levels was carried
out as described [42]. Dissociation curves demonstrated
that each primer pair amplified a single product. Standard
curves were prepared for each primer pair using serial
dilutions of human testis cDNA to enable calculation of
the relative abundance of each transcript type. The level of
SPAM1 ORF transcripts for each tissue was normalized to
GAPDH  and expressed relative to the level detected in
heart cDNA. The relative amounts of SPAM1 ERV1A and
ERV1B transcripts were assessed only in testis cDNA. The
level of each transcript was divided by the amount of ORF
transcript detected in testis. This value was then multi-
plied by the GAPDH- and heart-normalized level of ORF
transcripts to determine the contribution of each ERV pro-
moter to total SPAM1 expression. Primer pairs were as fol-
lows.  GAPDH, HGF2 & HGR2; Total SPAM1, HSF4 &
HSR4; SPAM1 Exon 1A, HSF5 & HSR5; SPAM1 Exon 1B,
HSF6 & HSR5.
List of abbreviations
ARE, androgen response element; CRE, cAMP response
element; CREM, CRE modulator; ERE, estrogen response
element; ERV, endogenous retrovirus; GAPDH, glyceral-
dehyde-3-phosphate dehydrogenase; LINE, long inter-
spersed nuclear element; LTR, long terminal repeat;
MAPK, mitogen activated protein kinase; ORF, open
reading frame; RACE, rapid amplification of cDNA ends;
SINE, short interspersed nuclear element; SPAM1, sperm
adhesion molecule 1; TE, transposable element; UCSC,
University of California at Santa Cruz; UTR, untranslated
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